Efficacy and safety of gefapixant for treatment of refractory or unexplained chronic cough: a systematic review and dose-response meta-analysis - Milan 2023

New frontiers in chronic cough, a1-antitrypsin deficiency, and airway diseases endoscopy

Chair(s): Gaetano Caramori, Mikael Adner

Session type: Poster session

Efficacy and safety of gefapixant for treatment of refractory or unexplained chronic cough: a systematic review and dose-response meta-analysis

Elena Kum

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Adherence to inhaled corticosteroids in patients with asthma prior to and during the first 12 months of COVID-19 pandemic

Miguel Santibanez Marguello

Poster

Abstract

Burden of disease in a phase 3b trial of gefapixant in women with chronic cough and stress urinary incontinence

Surinder S. Birring

Poster

Abstract

Late Breaking Abstract - Validation of assays measuring functional alpha-1 antitrypsin (AAT) in patients with AAT deficiency (AATD)

Carson Veldstra

Poster

Abstract

Does the type of Inhaler matter in cough variant or cough predominant asthma?

Marta Dabrowska

Poster

Abstract

Treatment of emphysema in patients with very severe alpha-1-antitrypsin deficiency

Emily F. A. Van 't Wout

Poster

Abstract

Cough responses to inhaled hypotonic solutions correlate with other measures of refractory chronic cough

James Wingfield Digby

Poster

Abstract

Smoking cessation improves lung function in heterozygote alpha-1 antitrypsin patients.

Dimitrios Toumpanakis

Poster

Abstract

Patient-reported cough severity in women with chronic cough and stress urinary incontinence treated with gefapixant

Peter Dicpinigaitis

Poster

Abstract

Association of changes in self-reported cough severity and cough-induced stress urinary incontinence (phase 3b gefapixant trial)

Peter Dicpinigaitis

Poster

Abstract

Early cough severity changes over the first 4 weeks of treatment with gefapixant in two phase 3 studies

Surinder S. Birring

Poster

Abstract

Efficacy and safety of gefapixant for treatment of refractory or unexplained chronic cough: a systematic review and dose-response meta-analysis

Elena Kum

Poster

Abstract

Demographics and subjective cough outcomes of guideline-based treatment in the McMaster Cough Clinic.

Mustafaa Wahab

Poster

Abstract

Acquired tracheal stenosis: what to do?

Kharrat Rania

Poster

Abstract

Manifestations and management of laryngoceles: A report of 10 cases

Rim Hammami

Poster

Abstract

Assessment of clinical outcome after endoscopic lung volume reduction with one-way valves in emphysema patients and a very-low 6 minute walk test at baseline

Jacopo Saccomanno

Abstract

Surfactant found in cleaning products, 4-tert-octylphenol, causes airway sensory nerves firing and airway smooth muscle contraction

Billy Peter Baxter

Poster

Abstract

Investigating the efficacy of a NaV1.7 channel blocker on airway sensory nerve activation and cough

Sara Bonvini

Poster

Abstract

Comparing neuronal phenotypes in two preclinical models of chronic lung disease

Jonathan H. A. Miles

Poster

Abstract

Relevance of cough in patients with severe asthma: Analysis from the Korean Severe Asthma Registry (KoSAR) study

Hwa Young Lee

Poster

Abstract

Late Breaking Abstract - Neutrophilic inflammation associates with dysregulated iron metabolism in COPD.

James Baker

Poster

Abstract

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}